tradingkey.logo

Jin Medical International Ltd

ZJYL

0.640USD

-0.001-0.09%
Market hours ETQuotes delayed by 15 min
100.21MMarket Cap
--P/E TTM
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2024H2
FY2024H1
FY2023H2
FY2023H1
Operating cash flows (indirect method)
Cash flow from continuing operating activities
-446.45%-1.26M
-98.18%50.00K
--362.91K
--2.74M
Net income from continuing operations
54.28%1.72M
-3.51%1.70M
--1.11M
--1.77M
Operating gains losses
59.71%177.98K
46.90%168.15K
--111.44K
--114.47K
Deferred tax
-40.03%12.62K
-65.42%23.71K
--21.04K
--68.56K
Other non-cash items
113.22%6.77K
-157.88%-99.28K
---51.19K
--171.52K
Change in working capital
-285.24%-3.17M
-381.25%-1.75M
---822.88K
--622.08K
-Change in receivables
-960.68%-2.88M
-882.52%-1.02M
---271.79K
---104.29K
-Change in inventory
-143.88%-486.42K
26.78%566.73K
--1.11M
--447.02K
-Change in prepaid expenses
92.89%-54.32K
-2854.35%-1.31M
---763.86K
--47.50K
-Change in payables and accrued expense
-183.61%-109.21K
806.93%206.42K
---38.51K
---29.20K
-Change in other current assets
----
----
----
--0.00
-Change in other current liabilities
-49.73%96.23K
6.54%-159.98K
--191.43K
---171.17K
Cash from non-recurring investing activities
Cash from operating activities
-446.45%-1.26M
-98.18%50.00K
--362.91K
--2.74M
Investing cash flow
Net cash from continuing investing activities
-35.55%59.86K
9649.17%1.06M
--92.89K
--10.91K
Capital expenditures
-40.47%61.27K
9563.81%1.06M
--102.92K
--11.01K
Net cash flow from disposal of fixed assets
-35.55%59.86K
9649.17%1.06M
--92.89K
--10.91K
Net cash flow from investment products
80.00%-1.06M
-218.15%-7.33M
---5.32M
---2.30M
Net cash flow from other investing activities
-189.07%-4.24M
189.07%4.24M
--4.76M
---4.76M
Cash from non-current investing activities
Net cash flow from investing activities
-717.28%-5.36M
41.34%-4.15M
---656.42K
---7.07M
Financing cash flow
Cash flow from continuous financing activities
575.09%5.65M
-25.87%6.00M
---1.19M
--8.10M
Net cash flow from debt Issuance/repayment
-53.47%1.31M
287.58%5.55M
--2.82M
--1.43M
Net cash flow from common stock issuance/repurchase
--0.00
-96.10%312.00K
--0.00
--8.00M
Net cash flow from preferred stock issuance/repurchase
----
100.00%0.00
--0.00
---1.21M
Proceeds from stock option exercised by employees
----
----
--336.64K
----
Net cash flow from other financing activities
199.78%4.34M
214.87%138.22K
---4.35M
---120.33K
Net cash from non-recurrent financing activities
Net cash from financing activities
575.09%5.65M
-25.87%6.00M
---1.19M
--8.10M
Net cash flow
Beginning cash balance
2.20%8.87M
44.59%6.93M
--8.68M
--4.79M
Current period cash flow changes
57.90%-738.72K
-50.01%1.95M
---1.75M
--3.89M
Effect of exchange rate changes
185.80%233.29K
-66.94%40.34K
---271.90K
--122.00K
Ending cash balance
17.41%8.14M
2.20%8.87M
--6.93M
--8.68M
Free cash flow
-607.17%-1.32M
-137.12%-1.01M
--259.99K
--2.73M
Currency unit
USD
USD
USD
USD
Audit opinions
--
--
--
--
KeyAI